Kane Biotech Inc Ord (KNBIF) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kane Biotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.719 Good day and thank you for standing by. Welcome to the Kean Biotech Q2 2023 00:00:05.719 -- 00:00:10.226 Financial Results Conference Call. At this time, all participants are in a listen-only 00:00:10.226 -- 00:00:14.432 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.432 -- 00:00:19.840 To ask a question during this session, please press star 1-1 on your telephone and 00:00:19.840 -- 00:00:24.207 wait for your name to be announced. To withdraw your question, please press star 1-1 00:00:24.207 -- 00:00:28.178 again. Please be advised that today's conference is being recorded. 00:00:28.178 -- 00:00:32.344 I would now like to hand the conference over to your speaker today, Nicole Sendi, Investor 00:00:32.344 -- 00:00:34.344 Relations. 00:00:47.125 -- 00:00:53.103 Nicole will cover Cane's financial and operating results for the second quarter of 2023. 00:00:53.103 -- 00:00:57.908 along with a discussion of some of our recent highlights and goals for 2023 00:00:57.908 -- 00:01:02.594 and beyond. Following our prepared remarks, we will open the conference call to a question 00:01:02.594 -- 00:01:08.220 and answer session. Our call today will be led by King's chief executive officer, 00:01:08.220 -- 00:01:10.223 Mark Edwards. 00:01:10.223 -- 00:01:14.267 Before we begin our formal remarks, I would like to remind everyone that some of the 00:01:14.267 -- 00:01:18.852 statements on this conference call contain certain forward looking information and statements 00:01:18.852 -- 00:01:23.242 within the meaning of securities law, which may not be based on historical fact. 00:01:23.242 -- 00:01:28.611 including, without limitation, statements containing the words believe, should, 00:01:28.611 -- 00:...